Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongxin Han

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Organic Chemistry|August 12, 2009
Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310Carmela Molinaro, Danny Gauvreau, Gregory Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidinesAustin Chen, Renee Aspiotis, Louis-Charles Campeau, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14)Joël Robichaud, Jean-François Fournier, Sébastien Gagné, et al.
The Journal of Biological Chemistry|June 12, 2002
Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injuryByung Hee Han, Daigen Xu, Junjeong Choi, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2008
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitorYongxin Han, Michel Belley, Christopher I Bayly, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory painJohn Colucci, Michael Boyd, Carl Berthelette, et al.
Journal of Cancer|September 21, 2017
CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent <i>In Vitro</i> and <i>In Vivo</i> Efficacy in the Treatment of Chronic Myeloid LeukemiaYinghui Sun, Na Zhao, Huan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Journal of Medicinal Chemistry|April 30, 2004
Reducing the peptidyl features of caspase-3 inhibitors: a structural analysisJoseph W Becker, Jennifer Rotonda, Stephen M Soisson, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Organic Chemistry|August 12, 2009
Remote electronic control in the regioselective reduction of succinimides: a practical, scalable synthesis of Ep4 antagonist MF-310Carmela Molinaro, Danny Gauvreau, Gregory Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2011
Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidinesAustin Chen, Renee Aspiotis, Louis-Charles Campeau, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14)Joël Robichaud, Jean-François Fournier, Sébastien Gagné, et al.
The Journal of Biological Chemistry|June 12, 2002
Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injuryByung Hee Han, Daigen Xu, Junjeong Choi, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2008
Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitorYongxin Han, Michel Belley, Christopher I Bayly, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory painJohn Colucci, Michael Boyd, Carl Berthelette, et al.
Journal of Cancer|September 21, 2017
CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent <i>In Vitro</i> and <i>In Vivo</i> Efficacy in the Treatment of Chronic Myeloid LeukemiaYinghui Sun, Na Zhao, Huan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Journal of Medicinal Chemistry|April 30, 2004
Reducing the peptidyl features of caspase-3 inhibitors: a structural analysisJoseph W Becker, Jennifer Rotonda, Stephen M Soisson, et al.
Pageof 7